Platinum Equity
Mergers. Acquisitions. Operations.

Mergers. Acquisitions. Operations.


Healthcare • Corporate Divestiture • Acquired in October 2018

A provider of blood glucose monitoring products and solutions for the treatment of diabetes

LifeScan, a Platinum Equity Portfolio Company, provides of blood glucose monitoring products and solutions.


  • Acquired LifeScan, Inc. from Johnson & Johnson in October 2018.  
  • LifeScan is a leading provider of blood glucose monitoring products and solutions for the treatment of diabetes.
  • The company develops, markets, and sells blood glucose monitoring systems for home and hospital use under the global brand OneTouch. The OneTouch portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions.
  • Company has co-headquarters in Chesterbrook, PA and Zug, Switzerland.


  • Execute complex, global carve-out across 90+ countries to form a new stand-up company.
  • Drive share and incremental value from digital data through continued investment in technologies and software.
  • Increase online, retail, and Point of Care presence in select markets.
  • Improve operations and supply chain.



Platinum Equity Submits Binding Offer to Acquire LifeScan from Johnson & Johnson »

Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc. »

Platinum Equity Completes $2.1 Billion Acquisition of LifeScan from Johnson & Johnson »


updated 10/18




Signing up for our Newsletter is subject to our Privacy Notice. You may unsubscribe at any time.

We are strongly committed to protecting your privacy. By submitting your contact information, you acknowledge that you have read our Privacy Notice and that you consent to our processing of data in accordance with our Privacy Notice.